ribavirin has been researched along with Age-Related Osteoporosis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bojunga, J; Bücker, A; Herrmann, E; Hofmann, WP; Kronenberger, B; Mihm, U; Sarrazin, C; Stamm, B; von Wagner, M; Zeuzem, S | 1 |
| Branch, AD; Gutierrez, JA; Parikh, N | 1 |
| Balduíno, A; Borojevic, R; Duarte, ME; Farias, ML; Martins, HS; Moreira, RO; Reis, JS | 1 |
| Bouloux, P; Hoffbrand, AV; Jensen, C; Telfer, P; Wonke, B | 1 |
| Castellano, G; Fernández, I; Hawkins, F; Muñoz, R; Solís-Herruzo, JA | 1 |
| Giostra, E; Mentha, G; Negro, F; Rizzoli, R; Trombetti, A | 1 |
2 review(s) available for ribavirin and Age-Related Osteoporosis
| Article | Year |
|---|---|
Classical and emerging roles of vitamin D in hepatitis C virus infection.
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Liver Neoplasms; Osteoporosis; Ribavirin; Vitamin D; Vitamin D Deficiency; Vitamins | 2011 |
New approaches to the management of hepatitis and endocrine disorders in Cooley's anemia.
Topics: Antiviral Agents; beta-Thalassemia; Child; Endocrine System Diseases; Female; Growth; Hepatitis C; Humans; Incidence; Interferon-alpha; Liver Cirrhosis; Osteoporosis; Pregnancy; Pregnancy Complications; Ribavirin; Sex Characteristics | 1998 |
1 trial(s) available for ribavirin and Age-Related Osteoporosis
| Article | Year |
|---|---|
Side effects. Bone problems may occur with hepatitis treatment.
Topics: Adult; Antiviral Agents; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Osteoporosis; Ribavirin | 2000 |
4 other study(ies) available for ribavirin and Age-Related Osteoporosis
| Article | Year |
|---|---|
Prospective study of bone mineral density and metabolism in patients with chronic hepatitis C during pegylated interferon alpha and ribavirin therapy.
Topics: Absorptiometry, Photon; Adult; Antiviral Agents; Bone and Bones; Bone Density; Collagen Type I; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Osteocalcin; Osteoporosis; Prospective Studies; Recombinant Proteins; Ribavirin | 2008 |
Ribavirin, but not interferon alpha-2b, is associated with impaired osteoblast proliferation and differentiation in vitro.
Topics: Alkaline Phosphatase; Bone Development; Cell Death; Cell Differentiation; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Interferon alpha-2; Interferon-alpha; Osteoblasts; Osteoporosis; Recombinant Proteins; Ribavirin; Tetrazolium Salts; Thiazoles; Time Factors | 2004 |
Decreased bone mineral density after therapy with alpha interferon in combination with ribavirin for chronic hepatitis C.
Topics: Bone Density; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Osteoporosis; Ribavirin | 2000 |
Lack of evidence for ribavirin-induced bone loss.
Topics: Bone Density; Female; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Osteoporosis; Ribavirin | 2002 |